•Big deals - $150M upfront, $1+B total
•Early deals – discovery platforms, preclinical compounds
•Clinical stage deals – Phase 1 thru Phase 3
•Territorial deals – China, Japan, US, Europe
•Technology deals
•Company acquisitions
•Profit sharing
•Co-development, Co-promotion
•University licenses
We do biotech partnering deals for clients.
Celebrating one of the biggest deals ever done in China - Lilly & Innovent
Some 100+ and counting with many more term sheets, giving advice or leading negotiations.
WE DO DEALS
Takeda Fronts $46M for 2nd small molecule collaboration with BridGene
Pearl Bio signs discovery collaboration with Merck
Bridgene Biosciences signs deal with Galapagos
AbbVie and Cugene Announce Collaboration
BridGene Collaboration with Peter MacCallum Cancer Centre
Vaccitech acquires Avidea Technologies
BridGene Partners with Takeda
Evoq Therapeutics Signs Deal with Amgen
Aeromics & Simcere Announce Collaboration